當(dāng)前位置：   首頁(yè) > 需求大廳

 >  特色服務(wù) 

1、Ophthalmic viscosurgical devices Article· Literature Review?in?Current Opinion in Ophthalmology 19(1):50-4 · February 2008?with?82 Reads DOI: 10.1097/ICU.0b013e3282f14db0 · Source: PubMed 2、Lancet Psychiatry. 2019 Mar;6(3):211-224. doi: 10.1016/S2215-0366(18)30511-X. Epub 2019 Feb 18. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Huang Y1, Wang Y2, Wang H3, Liu Z4, Yu X4, Yan J5, Yu Y6, Kou C6, Xu X7, Lu J7… PMID:30792114 3、Prevalence of myopia in local and international schools in Hong Kong. 4、Effects of different concentrations of atropine on controlling myopia in myopic children. 5、Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys 6、Effects of different concentrations of atropine on controlling myopia in myopic children. 7、Use of mechlorethamine gel in patients diagnosed with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL): “Real-world” experience from the Prospective Observational Study (PROVe) 8、Safety and effectiveness of tolvaptan administration after total arch replacement Yasunori Iida, MD, PhD, Akihiro Yoshitake, MD, PhD, Hideyuki Shimizu, MD, PhD 9、The role of tolvaptan administration after cardiac surgery: ameta-analysisIoannis Bellos MD , Dimitrios C. Iliopoulos MD, PhD ,Despina N. Perrea MD, PhD 10、Comparative bioavailability and in vitro in vivo correlation of two sustained release brands of theophylline: tablets and pellets.Tulain U, Ur-Rahman N.Pak J Pharm Sci. 2008 Apr;21(2):131-8. 11、Relative bioavailability and bioequivalence study of theophylline sustained release formulations. Vergin H, Mahr G, Winterhalter B, Wigand R.Arzneimittelforschung. 2003;53(9):635-9. 12、Use of mechlorethamine gel in patients diagnosed with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL): “Real-world” experience from the Prospective Observational Study (PROVe) 13、journal of medicinal chemistry 2004,47,530 14、Gupta AK, Ryder JE, Lynch LE et al. The use   [更多]

文獻(xiàn)： 1、Journal of Organic Chemistry1961vol. 26p. 2507 - 2510 2、J Contemp Dent Pract. 2016 Dec 1;17(12):1009-1012.Rebamipide to Manage Stomatopyrosis in Oral Submucous Fibrosis.Baptist J1, Shakya S2, Ongole R1. 3、heart failure with preserved ejection fraction：types 1 and 2 ？10.1016/j.jchf.2018.12.017 4、Current status of research on infantile cholestatic liver disease in China: a visualization analysis Author(s): LIAO Qiong, WAN Chao-Min, ZHU Yu, YANG Xiao-Yan, SHU Min, Department of Pediatrics, West China Second University Hospital, Sichuan University/Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Sichuan University 5、Diagnosis and differential diagnosis of infantile cholestasis disease Author(s): Dong Chen, Huang ZhihuaDong Chen: Department of Pediatrics, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China 6、In vitro dissolution and in vivo bioequivalence evaluation of two brands of isosorbide 5-mononitrate sustained release tablets.Kim YH1, Choi KS, Kam SH, Lee KH, Park JS 7、Evaluation of the bioequivalence and pharmacokinetics of two tablet formulations of isosorbide-5-mononitrate after single oral administration in healthy volunteers. Niopas I1, Daftsios AC, Nikolaidis N. 8、PK/PD analysis of Tebipenem Pivoxil (ME1211),a Novel Oral Carbapenem Antibiotic,in otolaryngological infections,a phase II clinical trial；（新型口服碳青霉烯類抗生素替比培南匹伏酯（ME1211）在耳鼻咽喉感染中的pk/pd分析，一項(xiàng)Ⅱ期臨床試驗(yàn)） 9、PK/PD analysis of Tebipenem Pivoxil (ME1211),a Novel Oral Carbapenem Antibiotic,in otolaryngological infections,a phase II clinical trial；（新型口服碳青霉烯類抗生素替比培南匹伏酯（ME1211）在耳鼻咽喉感染中的pk/pd分析，一項(xiàng)Ⅱ期臨床試驗(yàn)） 10、Trends in the Management of Acute Heart Failure Requiring Intensive Care Shirakabe A Kobayashi N, kazakh Matsushita M, Shibata Y -, Godah, Shigihara s", AsanKiuchit 11、Patient Selection for Tolvaptan Therapy Among Those With Chronic Kidney Disease and Heart Failure 12、Baumann;?Butler;   [更多]

求購(gòu)Oral Rehydration Salts BP2019 、USP42的藥典標(biāo)準(zhǔn)各一份，有其他國(guó)也可提供   [更多]

1.求購(gòu)下列中藥飲片標(biāo)準(zhǔn)、炮制規(guī)范（￥50/本）： 上海市中藥炮制規(guī)范1994年版 河北中藥材炮制規(guī)范 1979 山西炮制規(guī)范1984版、2007版、山西省中藥材中藥飲片標(biāo)準(zhǔn)第1冊(cè)(2017) 遼寧省中藥炮制規(guī)范1986版 吉林1962、1973版（暫行標(biāo)準(zhǔn)） 黑龍江1965、1991版 浙江1960、1977、1994版 安徽1980版、2018年版 江西1979、 1991 年版 山東2002版 河南1983版 湖北1983版、2019 湖南1977版 廣東藥材炮制手冊(cè)1963年版、廣東省中藥材飲片加工炮制手冊(cè)1977、廣東省中藥材炮制規(guī)范1984 貴州1964版 云南省中藥咀片炮制1974、昆明中藥咀片規(guī)范1963 甘肅1972、2009 青海省中藥炮制規(guī)范1982 年版、2008年版、青海省藏藥炮制規(guī)范 2010 內(nèi)蒙自治區(qū)1963、1977版 廣西自治區(qū)1985版 西藏自治區(qū) 藏藥炮制規(guī)范2008版 寧夏回族自治區(qū) 寧夏中藥炮制規(guī)范1997、1981版 新疆維吾爾自治區(qū) 自治區(qū)中藥維吾爾藥飲片炮制規(guī)范2010版 2.PDF文件要求：真實(shí)、無(wú)水印、完整、清晰，來(lái)源可靠（非網(wǎng)上百度所得）。 3.若發(fā)現(xiàn)文件有誤或不完整，相應(yīng)扣除一定的賞金。   [更多]

藥品信息匯編2002年 多巴絲肼顆?！?   [更多]

求購(gòu)《 EP9.6 》“Imidacloprid for veterinary use (2924) ”的藥典標(biāo)準(zhǔn)，以及任何相關(guān)制劑的Monograph。   [更多]

任務(wù)鏈接: http://www.sdcbcs.com/task/15538.html id: happinesslbh, 賞金:800+100 (數(shù)據(jù)處理質(zhì)優(yōu)獎(jiǎng)賞)   [更多]

賞金領(lǐng)?。?8*3+35*5=229   [更多]

收集了全國(guó)各省市的藥品中標(biāo)信息，為了保證給大家有更準(zhǔn)確及時(shí)的信息，需要 對(duì)藥品中標(biāo)信息數(shù)據(jù)庫(kù)及時(shí)更新，現(xiàn)請(qǐng)人進(jìn)行最新中標(biāo)數(shù)據(jù)的收集整理。 工作內(nèi)容：及時(shí)查到最新公布的藥品中標(biāo)信息，并將最新的文件按指定要求 處理成規(guī)范的格式(excel表)。交稿如發(fā)現(xiàn)遺漏，反饋后望及時(shí)補(bǔ)充。 補(bǔ)充月份：2019年2月-2019年7月（共6個(gè)月）   [更多]

ID：qwqwqw800 領(lǐng)取賞金   [更多]